FDA Grants First Approvals Via the Competitive Generic Therapy Pathway

International Pharmaceutical Regulatory Monitor
A A
The FDA approved drug products under the Competitive Generic Therapy (CGT) designation for the first time, granting approval to several strengths of Apotex’s potassium chloride oral solution.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00